Intelligence · Clinical Pipeline
Chinese Academy of Pipeline
All ClinicalTrials.gov programs at Chinese Academy of — phase, modality, and trial IDs.
- Programs
- 189
Quick answer
Chinese Academy of has 189 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Remimazolam besylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sedative
1 trial -
Riociguat
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Thromboembolic Pulmonary Hypertension
1 trial -
Romiplostim
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Immune Thrombocytopenia
1 trial -
Roux-en-Y anastomosis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Sacubitril-Valsartan
Xiyuan Hospital of China Academy of Chinese Medical Sciences
STEMI
1 trial -
Saline (0.9%, sterile, for infusion)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pneumocystis Jiroveci Pneumonia
1 trial -
Sirolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
Somatostatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gallbladder Neoplasms
1 trial -
Sorafenib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
2 trials -
Standard First-Line Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unresectable Colorectal Cancer
1 trial -
Start antiplatelet monotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intracerebral Hemorrhage
1 trial -
Steroid nasal spray
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-Induced Mucositis
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Neoplasms
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mediastinal Neoplasms
1 trial -
Supportive care+Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Minimal Change Disease
1 trial -
Suzhou Sceneray® DBS System
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Opiate Addiction
1 trial -
Systematic oral health education
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Malignant Tumor of Head and/or Neck
1 trial -
TCM
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer
1 trial -
TPO
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Tacrolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Transplantation
1 trial -
Tacrolimus capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Myasthenia Gravis
1 trial -
Tacrolimus capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
Tamoxifen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Female
1 trial -
Tang-min Lin pill
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes
1 trial -
Tegafur-Gimeracil-Oteracil Potassium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stomach Neoplasm
1 trial -
Tenecteplase (0.0938mg/kg)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Thoracoscopic Bullectomy Surgery
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stability During Surgical Operation
1 trial -
Ticagrelor and Aspirin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
Tislelizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonic Neoplasms
1 trial -
Tislelizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Rectal Carcinoma
1 trial -
Tislelizumab(neoadjuvant)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Head and Neck Squamous Cell Carcinomas
1 trial -
Tissue Plasminogen Activator (Alteplase)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stroke
1 trial -
Topical application of Periplaneta americana-derived Meilian Fuxin Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Dermatitis
1 trial -
Toripalimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
2 trials -
Toripalimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non Small Cell Lung Cancer
1 trial -
Traditional Chinese Medicine Prescription
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Traumastem®
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Hemorrhage
1 trial -
Treatment of TongBi Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Trichosanthes root
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Triplitode
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AIDS/HIV PROBLEM
1 trial -
VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Venetoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Lymphoblastic Leukemia
1 trial -
Venetoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
2 trials -
Ventoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML (Acute Myelogenous Leukemia)
1 trial -
Venues-P Valve
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Regurgitation
1 trial -
Verum acupuncture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial
Frequently asked questions
How many pipeline programs does Chinese Academy of have?
189 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs